Navigo and Mannin agree to develop a novel drug for treating COVID-19

Precision X affinity ligand will enable the efficient purification of the non-Fc fusion protein - News - PharmaTimes

Related Keywords

George Nikopoulos ,Mannin Research ,Acute Respiratory Disease Syndrome ,Navigo ,Plannin ,Partnership ,